Bloomage specializes in biomaterials and biotechnology, particularly in the production of hyaluronic acid raw materials, bioactive raw materials, and a range of finished products including HA dermal fillers, skin care products, orthopedics, and OVD, among others. Bloomage operates in over 70 countries and regions, holding various registrations, such as the CE mark for both HA raw materials and medical devices and US FDA approval for HA raw materials. Bloomage's HA raw materials business has captured 44% of the global market share as of 2021, and finished HA products are currently sold in Europe, Russia, southeast Asia, the Middle East, and South America.